Company news
PolTREG Spolka Akcyjna news in 2025
PolTREG Spolka Akcyjna's news releases, calls and decks from 2025, newest first.
PolTREG Doses First Patient in Phase II Trial for Pre-Symptomatic Type 1 Diabetes with PTG-007
August 4, 2025
PolTREG and U.S. Subsidiary Immuthera Secure Positive FDA Opinion, Paving the Way for a Registrational Pre-Symptomatic Type 1 Diabetes Trial
July 31, 2025
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy
June 13, 2025
Positive EMA Opinion on Pediatric Investigation Plan for PolTREG’s Treg Therapy in Type 1 Diabetes
May 15, 2025